European awards for Mumbai scientist's 'stem-cell' remedy to kill Covid-19

Mumbai scientistcumresearcher Pradeep Mahajan who recently developed a unique stemcellplateletbased remedy to kill the coronavirus naturally has bagged two top Global Health amp Pharma UK awards for his therapy here on TuesdayMahajan has been conferred the award for the Best Regenerative Medicine amp CellBased Therapies Development Company 2021 and the GHP Innovation Excellence Award for Mesenchymal Stem Cells and LPRP Manufacturing Services 2021 in a virtual ceremony from LondonThe GHP awards honour and acknowledge individuals and companies which go above and beyond to come up with breakthrough innovations and giving their valuable contribution to the scientific community and Mahajans achievement was first highlighted by IANS on May 10The Chairman of StemRx Biosciences Solutions Pvt Ltd Mahajan 61 says that the stemcelllyophilized platelet remedy is a proven protocol for Covid19 and postCovid19 patients on OPD basis without requiring hospitalization for targeting the primary lung diseaseHe said that the lungs are the prime target of Covid19 causing maximum morbidity highest stay in ICUVentilators and deaths and posttreatment the patient requires oxygen for several months as lungs develop fibrosisI am particularly positive about the use of platelet lysate for the treatment of postCovid19 Syndrome The different growth factors present in the concentrate play roles in cell migration stimulating cells to perform their functions more efficiently boosting blood supply and tissue repair among other things he saidAccordingly these factors can collectively help in reducing inflammation enhancing oxygenation reducing scar tissue etc all of which would help in symptom resolution and healthy tissue regeneration Mahajan addedThough it is important to consider individual symptoms as well as personalise the treatment protocols the overall goal should be to ensure that the core pathologies are targeted so as to prevent longterm functional disability of any kind he saidHe rued that while the world is still grappling with the second third fourth waves of the coronavirus pandemic there is no cohesive treatment protocol for the condition though its nearly oneandhalf years since it first attacked mankindMy team has developed a unique way to kill the virus naturally with antiinflammatory agents and reduce their prevalence slash the hospital stay of patients by 6575 per cent as many patients especially those who had acquired Covid19 severely experience multisystem issues termed as PostCovid19 Syndrome needing attention Mahajan saidWhile most drugs therapies and even vaccines target the Coronavirus rather than the environment in which it thrives so they do not give the desired success rate and in order to survive the virus continues to mutateHence for us to combat it we must develop a protocol with our own platelets which play a fundamental role in respiratory disorders resulting from viral infections being the first line of defence against viruses Mahajan pointed outThe clinical benefits of platelet concentrates have already been investigated and patented and now Mahajan plans to take it to benefit the maximum number of Covid19 infecteesThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever